Singapore markets closed

Straits Times Index
3,306.02
+6.02(+0.18%)
Nikkei
38,596.47
-36.55(-0.09%)
Hang Seng
18,028.52
-306.80(-1.67%)
FTSE 100
8,237.72
-34.74(-0.42%)
Bitcoin USD
64,373.32
+136.41(+0.21%)
CMC Crypto 200
1,351.69
-8.63(-0.63%)

BMY Jul 2024 45.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.2100

+0.0600

(+40.00%)

At close: 03:57PM EDT

Loading interactive chart…

Business Wire
Bristol Myers Squibb Announces U.S. FDA Accelerated Approval of KRAZATI® (adagrasib) in Combination with Cetuximab for Adult Patients with Previously Treated KRAS G12C-Mutated Locally Advanced or Metastatic Colorectal Cancer (CRC)
PRINCETON, N.J., June 21, 2024--Bristol Myers Squibb Announces U.S. FDA Accelerated Approval of KRAZATI® (adagrasib) in Combination with Cetuximab for Adult Patients with...
Business Wire
European Medicines Agency Validates Bristol Myers Squibb’s Application for Subcutaneous Nivolumab
PRINCETON, N.J., June 21, 2024--European Medicines Agency Validates Bristol Myers Squibb's Application for Subcutaneous Nivolumab
Business Wire
Bristol Myers Squibb to Report Results for Second Quarter 2024 on July 26, 2024
PRINCETON, N.J., June 20, 2024--Bristol Myers Squibb to Report Results for Second Quarter 2024 on July 26, 2024